Avichai Shimoni

Spécialisation: Hematologist
31 années d'expérience
Parle:
English, Hebrew
Consultations en ligne : disponibles
Espace de travail: Israël, Ramat Gan, Centre médical Sheba
Named among Israel’s Best Doctors by Forbes (2025–2026); Director of Bone Marrow Transplantation.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Consultation en ligne avec Avichai Shimoni

Pratique et facile

100 % sécurisé et confidentiel

$1,900

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

Prof. Avichai Shimoni, MD

Director, Bone Marrow Transplantation Department – Sheba Medical Center

World-Renowned Expert in Bone Marrow Transplantation & Cellular Therapy

Prof. Avichai Shimoni is a globally recognized hemato-oncologist with over 30 years of experience, specializing in bone marrow transplantation (BMT), cellular therapies, and advanced treatment of blood cancers.

As Director of the Bone Marrow Transplantation Department at Sheba Medical Center, he leads one of the most advanced and high-volume transplant programs in the region, treating patients with complex and high-risk hematologic malignancies.

Areas of Expertise

Bone Marrow Transplantation (Core Expertise)
- Allogeneic and autologous stem cell transplants
- Management of high-risk and relapsed disease
Advanced Cellular Therapies
- CAR-T Cell Therapy for leukemia, lymphoma, and multiple myeloma
- Integration of cutting-edge immunotherapy into clinical practice
Hematologic Malignancies
Acute leukemias (AML, ALL), CLL, NHL, Hodgkin lymphoma, MDS, CML, myelofibrosis, and multiple myeloma

International Training & Expertise

Prof. Shimoni completed advanced fellowship training in Bone Marrow Transplantation at MD Anderson Cancer Center, one of the world’s leading oncology institutions.

His clinical approach focuses on:

Delivering curative therapies for complex blood cancers
Combining transplantation with modern immunotherapy
Personalizing treatment based on disease biology and patient condition

Leadership & Academic Roles

Director, Bone Marrow Transplantation Department, Sheba Medical Center
Chairman, Department of Hematology, Tel Aviv University
Professor of Hematology

Prof. Shimoni plays a key role in training future hematologists and advancing clinical research in transplantation and cellular therapy.

Research & Recognition

Author of 250+ scientific publications
Leading research in CAR-T therapy and stem cell transplantation
Frequently recognized among Israel’s Best Doctors (Forbes 2025–2026)

Clinical Excellence

Prof. Shimoni is known for treating complex, high-risk cases, offering patients access to:

Advanced transplant techniques
Innovative cellular therapies
Multidisciplinary, highly coordinated care

His work bridges clinical practice and research, ensuring patients benefit from the latest medical advancements.

Patient-Centered Approach

Prof. Shimoni provides highly specialized, personalized care, focusing on:

Achieving the best possible clinical outcomes
Offering curative treatment options whenever possible
Supporting patients throughout complex treatment journeys

A Global Leader in Advanced Hemato-Oncology

Through his leadership in bone marrow transplantation and CAR-T therapy, Prof. Shimoni offers patients access to one of the most advanced and comprehensive blood cancer treatment programs worldwide.